首页> 美国卫生研究院文献>Journal of Korean Medical Science >Microalbuminuria is Independently Associated with Arterial Stiffness and Vascular Inflammation but not with Carotid Intima-Media Thickness in Patients with Newly Diagnosed Type 2 Diabetes or Essential Hypertension
【2h】

Microalbuminuria is Independently Associated with Arterial Stiffness and Vascular Inflammation but not with Carotid Intima-Media Thickness in Patients with Newly Diagnosed Type 2 Diabetes or Essential Hypertension

机译:新诊断的2型糖尿病或原发性高血压患者的微量白蛋白尿与动脉僵硬度和血管炎症独立相关但与颈动脉内膜中层厚度无关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The association between microalbuminuria (MAU) and the indices of macrovascular complication in patients with newly diagnosed type 2 diabetes (D) or essential hypertension (H) was evaluated. Total 446 patients were classified into four groups according to the urinary albumin-to-creatinine ratio: MAU-D (n = 104), normoalbuminuria (NAU)-D (n = 114), MAU-H (n = 116), and NAU-H (n = 112). The indices of macrovascular complication including arterial stiffness evaluated by pulse-wave-velocity (PWV), carotid intima-media thickness (IMT), and vascular inflammation marked by high-sensitivity C-reactive protein (hsCRP) were assessed. PWV, IMT, and hsCRP were higher in patients with MAU than in those with NAU in both diabetes and hypertension groups. In both MAU-D and MAU-H groups, PWV and hsCRP levels were positively correlated with MAU level (MAU-D: r = 0.47, 0.41, MAU-H: r = 0.36, 0.62, respectively, P < 0.05). Additionally, PWV and hsCRP were independent factors predicting MAU (diabetes group: OR 1.85, 1.54, hypertension group: OR 1.38, 1.51, respectively, P < 0.001), but not IMT. MAU is independently associated with arterial stiffness and vascular inflammation but not with IMT in patients with newly diagnosed type 2 diabetes or essential hypertension, which emphasizes the importance of proactive clinical investigations for atherosclerotic complications in patients with MAU, even in newly diagnosed diabetes or hypertension.
机译:评估了新诊断的2型糖尿病(D)或原发性高血压(H)患者的微量白蛋白尿(MAU)与大血管并发症指数之间的关联。根据尿白蛋白与肌酐的比例,将446位患者分为四组:MAU-D(n = 104),正常白蛋白尿(NAU)-D(n = 114),MAU-H(n = 116)和NAU-H(n = 112)。通过脉搏波速度(PWV),颈动脉内膜中层厚度(IMT)和以高敏C反应蛋白(hsCRP)为标志的血管炎症评估了包括血管僵硬度在内的大血管并发症指数。在糖尿病和高血压组中,MAU患者的PWV,IMT和hsCRP均高于NAU患者。在MAU-D和MAU-H组中,PWV和hsCRP水平均与MAU水平呈正相关(MAU-D:r = 0.47、0.41,MAU-H:r = 0.36、0.62,P <0.05)。此外,PWV和hsCRP是预测MAU的独立因素(糖尿病组:OR 1.85,1.54,高血压组:OR 1.38,1.51,P <0.001),而不是IMT。在新诊断的2型糖尿病或原发性高血压患者中,MAU与动脉僵硬和血管炎症独立相关,但与IMT无关,这强调了对MAU患者(即使是新诊断的糖尿病或高血压)的动脉粥样硬化并发症进行积极的临床研究的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号